Hepatic cancer was visually observed by histopathological evaluation (hepatic cord thickening and hepatic portal triad disruption etc.)and by testing for the HCC marker AFP (α-Feto protein), which was >3.00 fold higher at both the transcript as well as protein level when compared to control mice (Figure A in S1 File). The gene discussed is AFP; the disease is liver cancer.